Session Type
Meeting
Search Results for Failure
Abstract Number: M9
SHM Converge 2022
Background: We compared 1) monthly rates of hospitalizations by disease severity and heart failure types, 2) measures of in-hospital care process, 3) and 30-day clinical outcomes of patients with acute decompensated heart failure (ADHF) hospitalized during COVID-19 pandemic with those admitted in pre-pandemic periods. Methods: Retrospective study of 8989 ADHF hospitalizations (6769 unique patients, mean […]
Abstract Number: 108
SHM Converge 2021
Background: The novel coronavirus disease 2019 (COVID-19) has demonstrated a range of presentations and outcomes affecting multiple organ systems. Acute kidney injury (AKI) associated with hospitalized patients with COVID-19 and related outcomes vary widely according to early reports. This study aimed to determine the prevalence of AKI, AKI in the setting of chronic kidney disease […]
Abstract Number: 111
SHM Converge 2024
Background: Inpatient admissions for Congestive Heart Failure (CHF) represent a substantial economic burden within the US healthcare system with patients experiencing high rates of 30-day readmission and mortality. To more efficiently and effectively serve complex cardiovascular (CV) patients at a major cardiac care center, Intermountain Health created a dedicated CV hospitalist service which has expanded […]
Abstract Number: 114
SHM Converge 2021
Background: Heart failure is expected to increase in prevalence globally.(1) The increased incidence of metabolic disorders coupled with the increase in life expectancy in Singapore has contributed to this trend. Heart failure poses a great burden on patients, caregivers and the healthcare system.Previous European studies have suggested that patients managed by internists differ in baseline […]
Abstract Number: 117
SHM Converge 2021
Background: Serum levels of pro-B-type natriuretic peptide (BNP) and N-terminal (NT) proBNP are measured at admission to assess likelihood of acutely decompensated heart failure (ADHF). Pro-BNP, released by myocardium due to cardiac wall distention, is cleaved into the active BNP and inactive NT-proBNP forms. Elevated NT-proBNP levels on initial presentation are a reliable marker of […]
Abstract Number: 121
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Diuretic therapy is the mainstay of treatment for heart failure exacerbations but its optimal dosing strategy remains unclear. In 2011, the DOSE trial exhibited a trend toward improvement in patients’ global symptom assessments when utilizing a high-dose diuretic strategy, which used nearly 80mg intravenous furosemide three times daily in the first 72 hours on […]
Abstract Number: 131
SHM Converge 2023
Background: Management of heart failure (HF) patients revolves around optimization of guideline directed medical therapy (GDMT) and routine monitoring. Substance use plays a major role as the etiology of HF, especially in a low socioeconomic area with ethnic and racial minority patients. The aim of this study is to find the correlation of alcohol, tobacco […]
Abstract Number: 132
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Despite recent advancements in the medical management of acute and chronic Heart Failure (HF), smooth transitions of care for patients hospitalized with HF remain elusive for most health care systems. Use of home health services and other ancillary services have been promoted in recent years as a means of reducing readmission rates among HF […]
Abstract Number: 139
Hospital Medicine 2020, Virtual Competition
Background: Mitochondrial disease (MD) refers to a group of clinically heterogeneous disorders that result from dysfunctional oxidative phosphorylation and subsequent cellular incapability to meet energy demands. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonus, epilepsy, ataxia with ragged red fibers (MERRFs), chronic progressive ophthalmoplegia, Kearns–Sayre syndrome, and sensory ataxia neuropathy dysarthria ophthalmoplegia are among […]
Abstract Number: 141
Hospital Medicine 2020, Virtual Competition
Background: In patients hospitalized with heart failure (HF) exacerbations, physicians routinely supplement potassium to maintain levels ≥4.0 mEq/L. The evidence basis for this practice is relatively weak. We aimed to evaluate the association between serum potassium levels and outcomes in patients hospitalized with HF. Methods: We identified patients admitted with acute HF exacerbations to hospitals […]